跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TARO-CIPROFLOXACIN/DEXAMETHASONE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
TARO-CIPROFLOXACIN/DEXAMETHASONE
Authorized
STANDARD
TARO-CIPROFLOXACIN/DEXAMETHASONE
Taro Pharmaceuticals Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
113185223a61f1ca
Company
Taro Pharmaceuticals Inc
Type
Standard
Approval Details
Approval Id
113185223a61f1ca
Drug Approval Canada Name
TARO-CIPROFLOXACIN/DEXAMETHASONE
Product Name
TARO-CIPROFLOXACIN/DEXAMETHASONE
Status
Marketed
Status Date
2020-11-23
Original Market Date
2020-11-23
Din
02481901
Drug Class
Human
Dosage Form
Suspension
Route Of Administration
Otic
Schedule
Prescription
Ahfs
52:08.08
Atc Original
S02CA06 DEXAMETHASONE AND ANTIINFECTIVES
Atc Name
s 02 ca 06
Aig Number
0250083001
Company Name
Taro Pharmaceuticals Inc
Company Address
130 East Drive, Brampton, Ontario, Canada, L6T 1C1
Company Detail Path
/organization/taro-pharmaceuticals-inc
Company Information
Pharmaceutical Company Name
Taro Pharmaceuticals Inc
Country Name
Canada
Province Name
Ontario
City Name
brampton,ontario,country_ca
Address
130 East Dr
Active Ingredients
DEXAMETHASONE
0.1 % / W/V
CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE)
0.3 % / W/V
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
113185223a61f1ca
Type
Standard
Back to Health Canada Approvals